Completed PHASE4 INTERVENTIONAL 2-arm NCT01373411

Ticagrelor and Aspirin for the Prevention of Cardiovascular Events After Coronary Artery Bypass Surgery (TAP-CABG)

Ticagrelor and Aspirin for the Prevention of Cardiovascular Events After Coronary Artery Bypass Surgery (CABG)

Sponsor: Cardiology Research UBC

Updated 5 times since 2017 Last updated: Mar 24, 2015 Started: Sep 30, 2011 Primary completion: Mar 31, 2015 Completion: Mar 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01373411, this PHASE4 trial focuses on Coronary Artery Disease and remains completed. Sponsored by Cardiology Research UBC, it has been updated 5 times since 2011, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cardiology Research UBC
University of British Columbia

Data source: Cardiology Research UBC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vancouver, Canada